首页> 外文会议>International symposium on crystal engineering and drug delivery system >Evaluation of Chitosan Oligosaccharide Nanoparticles Prepared by A Novel Microemulsion-Coacervation Method
【24h】

Evaluation of Chitosan Oligosaccharide Nanoparticles Prepared by A Novel Microemulsion-Coacervation Method

机译:用新型微乳液凝聚法制备的壳聚糖寡糖纳米粒子的评价

获取原文

摘要

@@Chitosan oligosaccharide(COS)is the low molecular weight chitosan, which is more readily soluble than chitosan. Both chitosan and COS are biodegradable, biocompatible, and low-toxic materials, which are very popular in drug delivery system, especially as materials for developing micro/nanoparticles. The present approach for preparing chitosan nanoparticles, however, still have some drawbacks, such as low encapsulation rate, high toxicity induced by abundant emulsifier and cross linking agents. Herein, a novel microemulsion-coacervation technique was developed to prepare non-cross-linked chitosan oligosaccharides nanoparticles(COS-NPs). This technique is an improvement of emulsion cross-linking way which often used to prepare chitosan–based microspheres. The major improvement is avoiding toxicity from abundant emulsifier by adding co-emulsifier and glutaraldehyde as chemical crosslinker. Furthermore, the obtained nanoparticles were characterized and evaluated by its drug release mechanism, in vitro cytotoxicity and in vivo tissue distribution.
机译:@@壳聚糖寡糖(COS)是低分子量壳聚糖,比壳聚糖更容易溶解。壳聚糖和COS都是可生物降解的,生物相容性和低毒物材料,这些材料在药物递送系统中非常受欢迎,特别是作为开发微/纳米颗粒的材料。然而,制备壳聚糖纳米颗粒的本方法仍然具有一些缺点,例如通过浓度和交叉连接剂诱导的低封装率,毒性高的毒性。在此,开发了一种新型微乳液 - 凝聚技术以制备非交联的壳聚糖寡糖纳米颗粒(COS-NPS)。该技术是乳液交联方式的改善,其通常用于制备壳聚糖基微球。主要改善是通过将共乳化剂和戊二醛作为化学交联剂来避免丰富的乳化剂中的毒性。此外,通过其药物释放机制,体外细胞毒性和体内组织分布表征和评估所得纳米颗粒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号